Using machine learning to battle antibiotic resistance
Some researchers are training machine learning algorithms to identify known drug resistance genes in new strains of a pathogen. Others are using AI to hunt for entirely new resistance genes, seeking a better understanding of how bacteria fight off drug treatments. And some are moving into metagenomes, aiming to understand the resistance profile of environments such as wastewater effluent.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.